nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—HTR2C—obesity	0.357	1	CbGaD
Agomelatine—CYP1A2—Phentermine—obesity	0.0583	0.177	CbGbCtD
Agomelatine—CYP1A2—Phenylpropanolamine—obesity	0.0556	0.169	CbGbCtD
Agomelatine—CYP2C9—Phentermine—obesity	0.0525	0.159	CbGbCtD
Agomelatine—CYP1A2—Bupropion—obesity	0.0496	0.15	CbGbCtD
Agomelatine—CYP2C9—Bupropion—obesity	0.0447	0.135	CbGbCtD
Agomelatine—CYP1A2—Cimetidine—obesity	0.0364	0.11	CbGbCtD
Agomelatine—CYP2C9—Cimetidine—obesity	0.0328	0.0994	CbGbCtD
Agomelatine—Indomethacin—CES1—obesity	0.001	0.203	CrCbGaD
Agomelatine—Vision blurred—Phenylpropanolamine—obesity	0.00097	0.00662	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Methamphetamine—obesity	0.000966	0.00659	CcSEcCtD
Agomelatine—Tremor—Phenylpropanolamine—obesity	0.000964	0.00658	CcSEcCtD
Agomelatine—Nightmare—Sibutramine—obesity	0.000962	0.00656	CcSEcCtD
Agomelatine—Constipation—Methamphetamine—obesity	0.000957	0.00653	CcSEcCtD
Agomelatine—Hyperhidrosis—Phendimetrazine—obesity	0.000951	0.00648	CcSEcCtD
Agomelatine—Dyspepsia—Benzphetamine—obesity	0.00095	0.00648	CcSEcCtD
Agomelatine—Agitation—Phenylpropanolamine—obesity	0.000946	0.00645	CcSEcCtD
Agomelatine—Hepatitis—Cimetidine—obesity	0.000936	0.00639	CcSEcCtD
Agomelatine—Hallucination—Cimetidine—obesity	0.000932	0.00636	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Benzphetamine—obesity	0.000931	0.00635	CcSEcCtD
Agomelatine—Tremor—Phentermine—obesity	0.000923	0.00629	CcSEcCtD
Agomelatine—Agitation—Phentermine—obesity	0.000905	0.00617	CcSEcCtD
Agomelatine—Insomnia—Phendimetrazine—obesity	0.000889	0.00607	CcSEcCtD
Agomelatine—Urticaria—Methamphetamine—obesity	0.000889	0.00606	CcSEcCtD
Agomelatine—Naproxen—AKR1C3—obesity	0.00088	0.179	CrCbGaD
Agomelatine—Anxiety—Phenylpropanolamine—obesity	0.000873	0.00596	CcSEcCtD
Agomelatine—Abnormal dreams—Bupropion—obesity	0.000858	0.00586	CcSEcCtD
Agomelatine—Urticaria—Benzphetamine—obesity	0.000857	0.00585	CcSEcCtD
Agomelatine—Constipation—Phendimetrazine—obesity	0.000841	0.00574	CcSEcCtD
Agomelatine—Nightmare—Bupropion—obesity	0.000839	0.00572	CcSEcCtD
Agomelatine—Hepatic failure—Orlistat—obesity	0.000832	0.00567	CcSEcCtD
Agomelatine—Eczema—Orlistat—obesity	0.000832	0.00567	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Sibutramine—obesity	0.000832	0.00567	CcSEcCtD
Agomelatine—Dry mouth—Phentermine—obesity	0.00082	0.00559	CcSEcCtD
Agomelatine—Vision blurred—Diethylpropion—obesity	0.000807	0.00551	CcSEcCtD
Agomelatine—Eczema—Sibutramine—obesity	0.000805	0.00549	CcSEcCtD
Agomelatine—Tremor—Diethylpropion—obesity	0.000803	0.00548	CcSEcCtD
Agomelatine—Suicidal ideation—Topiramate—obesity	0.000789	0.00538	CcSEcCtD
Agomelatine—Agitation—Diethylpropion—obesity	0.000787	0.00537	CcSEcCtD
Agomelatine—Abdominal pain—Phendimetrazine—obesity	0.000777	0.0053	CcSEcCtD
Agomelatine—Diarrhoea—Methamphetamine—obesity	0.000765	0.00522	CcSEcCtD
Agomelatine—Mania—Topiramate—obesity	0.000761	0.00519	CcSEcCtD
Agomelatine—Insomnia—Phenylpropanolamine—obesity	0.00076	0.00518	CcSEcCtD
Agomelatine—Agitation—Cimetidine—obesity	0.000749	0.00511	CcSEcCtD
Agomelatine—Somnolence—Phenylpropanolamine—obesity	0.000747	0.00509	CcSEcCtD
Agomelatine—Dizziness—Methamphetamine—obesity	0.00074	0.00505	CcSEcCtD
Agomelatine—Diarrhoea—Benzphetamine—obesity	0.000738	0.00504	CcSEcCtD
Agomelatine—Insomnia—Phentermine—obesity	0.000727	0.00496	CcSEcCtD
Agomelatine—Anxiety—Diethylpropion—obesity	0.000727	0.00496	CcSEcCtD
Agomelatine—Rash erythematous—Topiramate—obesity	0.000723	0.00493	CcSEcCtD
Agomelatine—Constipation—Phenylpropanolamine—obesity	0.000718	0.0049	CcSEcCtD
Agomelatine—Dizziness—Benzphetamine—obesity	0.000713	0.00487	CcSEcCtD
Agomelatine—Dry mouth—Diethylpropion—obesity	0.000713	0.00487	CcSEcCtD
Agomelatine—Indomethacin—AKR1C3—obesity	0.000713	0.145	CrCbGaD
Agomelatine—Migraine—Sibutramine—obesity	0.000712	0.00486	CcSEcCtD
Agomelatine—Dyspepsia—Phentermine—obesity	0.000708	0.00483	CcSEcCtD
Agomelatine—Eczema—Bupropion—obesity	0.000702	0.00479	CcSEcCtD
Agomelatine—Headache—Methamphetamine—obesity	0.000701	0.00478	CcSEcCtD
Agomelatine—Face oedema—Sibutramine—obesity	0.000698	0.00476	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Phentermine—obesity	0.000694	0.00473	CcSEcCtD
Agomelatine—Fatigue—Phentermine—obesity	0.000693	0.00473	CcSEcCtD
Agomelatine—Anxiety—Cimetidine—obesity	0.000692	0.00472	CcSEcCtD
Agomelatine—Constipation—Phentermine—obesity	0.000687	0.00469	CcSEcCtD
Agomelatine—Hyperhidrosis—Diethylpropion—obesity	0.000676	0.00461	CcSEcCtD
Agomelatine—Headache—Benzphetamine—obesity	0.000676	0.00461	CcSEcCtD
Agomelatine—Diarrhoea—Phendimetrazine—obesity	0.000673	0.00459	CcSEcCtD
Agomelatine—Dizziness—Phendimetrazine—obesity	0.00065	0.00444	CcSEcCtD
Agomelatine—Influenza—Orlistat—obesity	0.000646	0.00441	CcSEcCtD
Agomelatine—Nausea—Benzphetamine—obesity	0.000641	0.00437	CcSEcCtD
Agomelatine—Urticaria—Phentermine—obesity	0.000639	0.00436	CcSEcCtD
Agomelatine—Abdominal pain—Phentermine—obesity	0.000635	0.00433	CcSEcCtD
Agomelatine—Insomnia—Diethylpropion—obesity	0.000632	0.00431	CcSEcCtD
Agomelatine—Aggression—Topiramate—obesity	0.00063	0.0043	CcSEcCtD
Agomelatine—Influenza—Sibutramine—obesity	0.000625	0.00426	CcSEcCtD
Agomelatine—Somnolence—Diethylpropion—obesity	0.000622	0.00424	CcSEcCtD
Agomelatine—Migraine—Bupropion—obesity	0.000621	0.00423	CcSEcCtD
Agomelatine—Indomethacin—PPARA—obesity	0.000619	0.126	CrCbGaD
Agomelatine—Headache—Phendimetrazine—obesity	0.000616	0.0042	CcSEcCtD
Agomelatine—Dyspepsia—Diethylpropion—obesity	0.000616	0.0042	CcSEcCtD
Agomelatine—Face oedema—Bupropion—obesity	0.000609	0.00415	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Diethylpropion—obesity	0.000604	0.00412	CcSEcCtD
Agomelatine—Irritability—Bupropion—obesity	0.000602	0.00411	CcSEcCtD
Agomelatine—Constipation—Diethylpropion—obesity	0.000598	0.00408	CcSEcCtD
Agomelatine—Somnolence—Cimetidine—obesity	0.000591	0.00404	CcSEcCtD
Agomelatine—Nausea—Phendimetrazine—obesity	0.000584	0.00398	CcSEcCtD
Agomelatine—Asthenia—Phentermine—obesity	0.000577	0.00393	CcSEcCtD
Agomelatine—Infestation NOS—Orlistat—obesity	0.000576	0.00393	CcSEcCtD
Agomelatine—Infestation—Orlistat—obesity	0.000576	0.00393	CcSEcCtD
Agomelatine—Depression—Orlistat—obesity	0.000574	0.00392	CcSEcCtD
Agomelatine—Fatigue—Cimetidine—obesity	0.000574	0.00391	CcSEcCtD
Agomelatine—Constipation—Cimetidine—obesity	0.000569	0.00388	CcSEcCtD
Agomelatine—Weight increased—Sibutramine—obesity	0.000569	0.00388	CcSEcCtD
Agomelatine—Nasopharyngitis—Bupropion—obesity	0.000564	0.00385	CcSEcCtD
Agomelatine—Depression—Sibutramine—obesity	0.000556	0.00379	CcSEcCtD
Agomelatine—Urticaria—Diethylpropion—obesity	0.000555	0.00379	CcSEcCtD
Agomelatine—Dizziness—Phenylpropanolamine—obesity	0.000555	0.00379	CcSEcCtD
Agomelatine—Phosphatase alkaline increased—Topiramate—obesity	0.000553	0.00378	CcSEcCtD
Agomelatine—Diarrhoea—Phentermine—obesity	0.00055	0.00375	CcSEcCtD
Agomelatine—Influenza—Bupropion—obesity	0.000545	0.00372	CcSEcCtD
Agomelatine—Hepatobiliary disease—Orlistat—obesity	0.000545	0.00372	CcSEcCtD
Agomelatine—Vomiting—Phenylpropanolamine—obesity	0.000534	0.00364	CcSEcCtD
Agomelatine—Dizziness—Phentermine—obesity	0.000532	0.00363	CcSEcCtD
Agomelatine—Hepatitis—Orlistat—obesity	0.000517	0.00353	CcSEcCtD
Agomelatine—Vomiting—Phentermine—obesity	0.000511	0.00349	CcSEcCtD
Agomelatine—Headache—Phentermine—obesity	0.000504	0.00344	CcSEcCtD
Agomelatine—Nausea—Phenylpropanolamine—obesity	0.000499	0.0034	CcSEcCtD
Agomelatine—Weight increased—Bupropion—obesity	0.000496	0.00338	CcSEcCtD
Agomelatine—Weight decreased—Bupropion—obesity	0.000493	0.00336	CcSEcCtD
Agomelatine—Infestation—Bupropion—obesity	0.000486	0.00331	CcSEcCtD
Agomelatine—Infestation NOS—Bupropion—obesity	0.000486	0.00331	CcSEcCtD
Agomelatine—Diarrhoea—Diethylpropion—obesity	0.000478	0.00326	CcSEcCtD
Agomelatine—Nausea—Phentermine—obesity	0.000477	0.00326	CcSEcCtD
Agomelatine—Asthenia—Cimetidine—obesity	0.000477	0.00326	CcSEcCtD
Agomelatine—Jaundice—Bupropion—obesity	0.000474	0.00323	CcSEcCtD
Agomelatine—Eye disorder—Sibutramine—obesity	0.000468	0.00319	CcSEcCtD
Agomelatine—Tinnitus—Sibutramine—obesity	0.000467	0.00318	CcSEcCtD
Agomelatine—Dizziness—Diethylpropion—obesity	0.000462	0.00315	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Topiramate—obesity	0.000462	0.00315	CcSEcCtD
Agomelatine—Diarrhoea—Cimetidine—obesity	0.000455	0.00311	CcSEcCtD
Agomelatine—Mental disorder—Orlistat—obesity	0.000453	0.00309	CcSEcCtD
Agomelatine—Hepatic failure—Topiramate—obesity	0.000447	0.00305	CcSEcCtD
Agomelatine—Eczema—Topiramate—obesity	0.000447	0.00305	CcSEcCtD
Agomelatine—Vomiting—Diethylpropion—obesity	0.000445	0.00303	CcSEcCtD
Agomelatine—Dizziness—Cimetidine—obesity	0.00044	0.003	CcSEcCtD
Agomelatine—Headache—Diethylpropion—obesity	0.000438	0.00299	CcSEcCtD
Agomelatine—Hepatitis—Bupropion—obesity	0.000436	0.00298	CcSEcCtD
Agomelatine—Back pain—Orlistat—obesity	0.000435	0.00297	CcSEcCtD
Agomelatine—Hallucination—Bupropion—obesity	0.000434	0.00296	CcSEcCtD
Agomelatine—Connective tissue disorder—Bupropion—obesity	0.000429	0.00292	CcSEcCtD
Agomelatine—Vision blurred—Orlistat—obesity	0.000424	0.00289	CcSEcCtD
Agomelatine—Vomiting—Cimetidine—obesity	0.000423	0.00289	CcSEcCtD
Agomelatine—Back pain—Sibutramine—obesity	0.000421	0.00287	CcSEcCtD
Agomelatine—Headache—Cimetidine—obesity	0.000417	0.00284	CcSEcCtD
Agomelatine—Nausea—Diethylpropion—obesity	0.000415	0.00283	CcSEcCtD
Agomelatine—Angioedema—Orlistat—obesity	0.000411	0.00281	CcSEcCtD
Agomelatine—Vision blurred—Sibutramine—obesity	0.00041	0.0028	CcSEcCtD
Agomelatine—Tremor—Sibutramine—obesity	0.000408	0.00278	CcSEcCtD
Agomelatine—Eye disorder—Bupropion—obesity	0.000408	0.00278	CcSEcCtD
Agomelatine—Tinnitus—Bupropion—obesity	0.000407	0.00277	CcSEcCtD
Agomelatine—Vertigo—Orlistat—obesity	0.000404	0.00276	CcSEcCtD
Agomelatine—Agitation—Sibutramine—obesity	0.0004	0.00273	CcSEcCtD
Agomelatine—Angioedema—Sibutramine—obesity	0.000398	0.00272	CcSEcCtD
Agomelatine—Migraine—Topiramate—obesity	0.000395	0.0027	CcSEcCtD
Agomelatine—Nausea—Cimetidine—obesity	0.000395	0.0027	CcSEcCtD
Agomelatine—Vertigo—Sibutramine—obesity	0.000391	0.00267	CcSEcCtD
Agomelatine—Face oedema—Topiramate—obesity	0.000388	0.00265	CcSEcCtD
Agomelatine—Irritability—Topiramate—obesity	0.000383	0.00262	CcSEcCtD
Agomelatine—Mental disorder—Bupropion—obesity	0.000382	0.00261	CcSEcCtD
Agomelatine—Anxiety—Orlistat—obesity	0.000382	0.0026	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000381	0.0026	CcSEcCtD
Agomelatine—Dry mouth—Orlistat—obesity	0.000375	0.00256	CcSEcCtD
Agomelatine—Anxiety—Sibutramine—obesity	0.00037	0.00252	CcSEcCtD
Agomelatine—Back pain—Bupropion—obesity	0.000367	0.00251	CcSEcCtD
Agomelatine—Infection—Orlistat—obesity	0.000365	0.00249	CcSEcCtD
Agomelatine—Dry mouth—Sibutramine—obesity	0.000363	0.00247	CcSEcCtD
Agomelatine—Nervous system disorder—Orlistat—obesity	0.00036	0.00246	CcSEcCtD
Agomelatine—Nasopharyngitis—Topiramate—obesity	0.000359	0.00245	CcSEcCtD
Agomelatine—Vision blurred—Bupropion—obesity	0.000358	0.00244	CcSEcCtD
Agomelatine—Skin disorder—Orlistat—obesity	0.000357	0.00243	CcSEcCtD
Agomelatine—Tremor—Bupropion—obesity	0.000356	0.00243	CcSEcCtD
Agomelatine—Hyperhidrosis—Orlistat—obesity	0.000355	0.00242	CcSEcCtD
Agomelatine—Infection—Sibutramine—obesity	0.000353	0.00241	CcSEcCtD
Agomelatine—Agitation—Bupropion—obesity	0.000349	0.00238	CcSEcCtD
Agomelatine—Angioedema—Bupropion—obesity	0.000347	0.00237	CcSEcCtD
Agomelatine—Skin disorder—Sibutramine—obesity	0.000345	0.00236	CcSEcCtD
Agomelatine—Hyperhidrosis—Sibutramine—obesity	0.000344	0.00234	CcSEcCtD
Agomelatine—Vertigo—Bupropion—obesity	0.000341	0.00233	CcSEcCtD
Agomelatine—Nabumetone—PTGS2—obesity	0.000334	0.0677	CrCbGaD
Agomelatine—Insomnia—Orlistat—obesity	0.000332	0.00227	CcSEcCtD
Agomelatine—Paraesthesia—Orlistat—obesity	0.00033	0.00225	CcSEcCtD
Agomelatine—Dyspepsia—Orlistat—obesity	0.000323	0.00221	CcSEcCtD
Agomelatine—Anxiety—Bupropion—obesity	0.000322	0.0022	CcSEcCtD
Agomelatine—Insomnia—Sibutramine—obesity	0.000322	0.00219	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000321	0.00219	CcSEcCtD
Agomelatine—Paraesthesia—Sibutramine—obesity	0.000319	0.00218	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Orlistat—obesity	0.000317	0.00216	CcSEcCtD
Agomelatine—Fatigue—Orlistat—obesity	0.000317	0.00216	CcSEcCtD
Agomelatine—Dry mouth—Bupropion—obesity	0.000316	0.00216	CcSEcCtD
Agomelatine—Somnolence—Sibutramine—obesity	0.000316	0.00216	CcSEcCtD
Agomelatine—Weight increased—Topiramate—obesity	0.000316	0.00216	CcSEcCtD
Agomelatine—Weight decreased—Topiramate—obesity	0.000314	0.00214	CcSEcCtD
Agomelatine—Dyspepsia—Sibutramine—obesity	0.000313	0.00213	CcSEcCtD
Agomelatine—Infestation NOS—Topiramate—obesity	0.00031	0.00211	CcSEcCtD
Agomelatine—Infestation—Topiramate—obesity	0.00031	0.00211	CcSEcCtD
Agomelatine—Depression—Topiramate—obesity	0.000309	0.00211	CcSEcCtD
Agomelatine—Infection—Bupropion—obesity	0.000308	0.0021	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Sibutramine—obesity	0.000307	0.00209	CcSEcCtD
Agomelatine—Constipation—Sibutramine—obesity	0.000304	0.00207	CcSEcCtD
Agomelatine—Nervous system disorder—Bupropion—obesity	0.000304	0.00207	CcSEcCtD
Agomelatine—Skin disorder—Bupropion—obesity	0.000301	0.00205	CcSEcCtD
Agomelatine—Gastrointestinal pain—Orlistat—obesity	0.0003	0.00205	CcSEcCtD
Agomelatine—Hyperhidrosis—Bupropion—obesity	0.0003	0.00204	CcSEcCtD
Agomelatine—Indomethacin—PPARG—obesity	0.000296	0.0601	CrCbGaD
Agomelatine—Urticaria—Orlistat—obesity	0.000292	0.00199	CcSEcCtD
Agomelatine—Gastrointestinal pain—Sibutramine—obesity	0.000291	0.00198	CcSEcCtD
Agomelatine—Abdominal pain—Orlistat—obesity	0.00029	0.00198	CcSEcCtD
Agomelatine—Melatonin—CYP19A1—obesity	0.000289	0.0586	CrCbGaD
Agomelatine—Urticaria—Sibutramine—obesity	0.000282	0.00193	CcSEcCtD
Agomelatine—Abdominal pain—Sibutramine—obesity	0.000281	0.00192	CcSEcCtD
Agomelatine—Insomnia—Bupropion—obesity	0.00028	0.00191	CcSEcCtD
Agomelatine—Paraesthesia—Bupropion—obesity	0.000278	0.0019	CcSEcCtD
Agomelatine—Hepatitis—Topiramate—obesity	0.000278	0.0019	CcSEcCtD
Agomelatine—Hallucination—Topiramate—obesity	0.000277	0.00189	CcSEcCtD
Agomelatine—Somnolence—Bupropion—obesity	0.000276	0.00188	CcSEcCtD
Agomelatine—Connective tissue disorder—Topiramate—obesity	0.000273	0.00186	CcSEcCtD
Agomelatine—Dyspepsia—Bupropion—obesity	0.000273	0.00186	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Bupropion—obesity	0.000268	0.00183	CcSEcCtD
Agomelatine—Fatigue—Bupropion—obesity	0.000267	0.00182	CcSEcCtD
Agomelatine—Melatonin—ESR1—obesity	0.000266	0.054	CrCbGaD
Agomelatine—Constipation—Bupropion—obesity	0.000265	0.00181	CcSEcCtD
Agomelatine—Asthenia—Orlistat—obesity	0.000264	0.0018	CcSEcCtD
Agomelatine—Pruritus—Orlistat—obesity	0.00026	0.00177	CcSEcCtD
Agomelatine—Eye disorder—Topiramate—obesity	0.00026	0.00177	CcSEcCtD
Agomelatine—Tinnitus—Topiramate—obesity	0.000259	0.00177	CcSEcCtD
Agomelatine—Asthenia—Sibutramine—obesity	0.000255	0.00174	CcSEcCtD
Agomelatine—Gastrointestinal pain—Bupropion—obesity	0.000253	0.00173	CcSEcCtD
Agomelatine—Pruritus—Sibutramine—obesity	0.000252	0.00172	CcSEcCtD
Agomelatine—Diarrhoea—Orlistat—obesity	0.000251	0.00171	CcSEcCtD
Agomelatine—Urticaria—Bupropion—obesity	0.000246	0.00168	CcSEcCtD
Agomelatine—Abdominal pain—Bupropion—obesity	0.000245	0.00167	CcSEcCtD
Agomelatine—Mental disorder—Topiramate—obesity	0.000243	0.00166	CcSEcCtD
Agomelatine—Diarrhoea—Sibutramine—obesity	0.000243	0.00166	CcSEcCtD
Agomelatine—Dizziness—Orlistat—obesity	0.000243	0.00166	CcSEcCtD
Agomelatine—Dizziness—Sibutramine—obesity	0.000235	0.0016	CcSEcCtD
Agomelatine—Back pain—Topiramate—obesity	0.000234	0.0016	CcSEcCtD
Agomelatine—Vomiting—Orlistat—obesity	0.000234	0.00159	CcSEcCtD
Agomelatine—Headache—Orlistat—obesity	0.00023	0.00157	CcSEcCtD
Agomelatine—Vision blurred—Topiramate—obesity	0.000228	0.00156	CcSEcCtD
Agomelatine—Tremor—Topiramate—obesity	0.000227	0.00155	CcSEcCtD
Agomelatine—Vomiting—Sibutramine—obesity	0.000226	0.00154	CcSEcCtD
Agomelatine—Headache—Sibutramine—obesity	0.000223	0.00152	CcSEcCtD
Agomelatine—Asthenia—Bupropion—obesity	0.000222	0.00152	CcSEcCtD
Agomelatine—Agitation—Topiramate—obesity	0.000222	0.00152	CcSEcCtD
Agomelatine—Pruritus—Bupropion—obesity	0.000219	0.0015	CcSEcCtD
Agomelatine—Nausea—Orlistat—obesity	0.000218	0.00149	CcSEcCtD
Agomelatine—Vertigo—Topiramate—obesity	0.000217	0.00148	CcSEcCtD
Agomelatine—Diarrhoea—Bupropion—obesity	0.000212	0.00145	CcSEcCtD
Agomelatine—Nausea—Sibutramine—obesity	0.000211	0.00144	CcSEcCtD
Agomelatine—Anxiety—Topiramate—obesity	0.000205	0.0014	CcSEcCtD
Agomelatine—Dizziness—Bupropion—obesity	0.000205	0.0014	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000205	0.0014	CcSEcCtD
Agomelatine—Dry mouth—Topiramate—obesity	0.000201	0.00137	CcSEcCtD
Agomelatine—Vomiting—Bupropion—obesity	0.000197	0.00134	CcSEcCtD
Agomelatine—Infection—Topiramate—obesity	0.000196	0.00134	CcSEcCtD
Agomelatine—Headache—Bupropion—obesity	0.000194	0.00132	CcSEcCtD
Agomelatine—Nervous system disorder—Topiramate—obesity	0.000194	0.00132	CcSEcCtD
Agomelatine—Skin disorder—Topiramate—obesity	0.000192	0.00131	CcSEcCtD
Agomelatine—Hyperhidrosis—Topiramate—obesity	0.000191	0.0013	CcSEcCtD
Agomelatine—Nausea—Bupropion—obesity	0.000184	0.00126	CcSEcCtD
Agomelatine—Insomnia—Topiramate—obesity	0.000179	0.00122	CcSEcCtD
Agomelatine—Paraesthesia—Topiramate—obesity	0.000177	0.00121	CcSEcCtD
Agomelatine—Somnolence—Topiramate—obesity	0.000176	0.0012	CcSEcCtD
Agomelatine—Dyspepsia—Topiramate—obesity	0.000174	0.00119	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Topiramate—obesity	0.00017	0.00116	CcSEcCtD
Agomelatine—Fatigue—Topiramate—obesity	0.00017	0.00116	CcSEcCtD
Agomelatine—Constipation—Topiramate—obesity	0.000169	0.00115	CcSEcCtD
Agomelatine—Gastrointestinal pain—Topiramate—obesity	0.000161	0.0011	CcSEcCtD
Agomelatine—Urticaria—Topiramate—obesity	0.000157	0.00107	CcSEcCtD
Agomelatine—Abdominal pain—Topiramate—obesity	0.000156	0.00106	CcSEcCtD
Agomelatine—Naproxen—PTGS2—obesity	0.000154	0.0313	CrCbGaD
Agomelatine—Asthenia—Topiramate—obesity	0.000142	0.000966	CcSEcCtD
Agomelatine—Pruritus—Topiramate—obesity	0.00014	0.000953	CcSEcCtD
Agomelatine—Naproxen—ALB—obesity	0.000137	0.0279	CrCbGaD
Agomelatine—Diarrhoea—Topiramate—obesity	0.000135	0.000922	CcSEcCtD
Agomelatine—Dizziness—Topiramate—obesity	0.000131	0.000891	CcSEcCtD
Agomelatine—Vomiting—Topiramate—obesity	0.000126	0.000856	CcSEcCtD
Agomelatine—Indomethacin—PTGS2—obesity	0.000125	0.0254	CrCbGaD
Agomelatine—Headache—Topiramate—obesity	0.000124	0.000844	CcSEcCtD
Agomelatine—Nausea—Topiramate—obesity	0.000117	0.0008	CcSEcCtD
Agomelatine—Indomethacin—ALB—obesity	0.000111	0.0226	CrCbGaD
Agomelatine—HTR2C—Signaling Pathways—FOXO3—obesity	6.95e-06	4.29e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADRB2—obesity	6.93e-06	4.28e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CLOCK—obesity	6.92e-06	4.28e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC22A1—obesity	6.92e-06	4.28e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—obesity	6.9e-06	4.27e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—obesity	6.87e-06	4.24e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PRKCD—obesity	6.86e-06	4.24e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—obesity	6.84e-06	4.23e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SOCS1—obesity	6.83e-06	4.22e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—obesity	6.82e-06	4.22e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—G6PD—obesity	6.78e-06	4.19e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CD—obesity	6.77e-06	4.18e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GLP1R—obesity	6.74e-06	4.17e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SULT2A1—obesity	6.74e-06	4.17e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SOCS3—obesity	6.74e-06	4.17e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR2A—obesity	6.72e-06	4.15e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—C3—obesity	6.71e-06	4.14e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SREBF2—obesity	6.69e-06	4.14e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HK1—obesity	6.69e-06	4.14e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—obesity	6.69e-06	4.13e-05	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AKT1—obesity	6.66e-06	4.12e-05	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AKT1—obesity	6.66e-06	4.12e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—DPYD—obesity	6.63e-06	4.1e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GNB3—obesity	6.6e-06	4.08e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TYK2—obesity	6.51e-06	4.02e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CB—obesity	6.49e-06	4.01e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF2—obesity	6.48e-06	4.01e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LPA—obesity	6.47e-06	3.99e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—RHOA—obesity	6.46e-06	3.99e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GNAS—obesity	6.43e-06	3.97e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3R1—obesity	6.39e-06	3.95e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PRKAR2B—obesity	6.39e-06	3.95e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IRS2—obesity	6.38e-06	3.94e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGT—obesity	6.37e-06	3.94e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—DCN—obesity	6.34e-06	3.92e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LPIN1—obesity	6.33e-06	3.91e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOB—obesity	6.29e-06	3.89e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOE—obesity	6.24e-06	3.86e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LEP—obesity	6.24e-06	3.86e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—obesity	6.23e-06	3.85e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—obesity	6.22e-06	3.84e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOA5—obesity	6.2e-06	3.83e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CAV1—obesity	6.19e-06	3.82e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOA1—obesity	6.17e-06	3.81e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CPT1A—obesity	6.17e-06	3.81e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL5—obesity	6.15e-06	3.8e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NAMPT—obesity	6.05e-06	3.74e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—obesity	6.02e-06	3.72e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—obesity	6.01e-06	3.72e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LIPC—obesity	6.01e-06	3.71e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GCK—obesity	6.01e-06	3.71e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LPL—obesity	6.01e-06	3.71e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOC3—obesity	5.97e-06	3.69e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FOXO1—obesity	5.97e-06	3.69e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ESR1—obesity	5.96e-06	3.68e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RPS6KB1—obesity	5.96e-06	3.68e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—obesity	5.93e-06	3.66e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC22A1—obesity	5.91e-06	3.65e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CLOCK—obesity	5.91e-06	3.65e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—obesity	5.9e-06	3.64e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CB—obesity	5.9e-06	3.64e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—F2—obesity	5.89e-06	3.64e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PRKCB—obesity	5.89e-06	3.64e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—obesity	5.85e-06	3.61e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—obesity	5.83e-06	3.6e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—BAD—obesity	5.82e-06	3.59e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CETP—obesity	5.8e-06	3.58e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SULT2A1—obesity	5.76e-06	3.56e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GLP1R—obesity	5.76e-06	3.56e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SDC1—obesity	5.73e-06	3.54e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—DPYD—obesity	5.67e-06	3.5e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AKR1C3—obesity	5.64e-06	3.49e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CG—obesity	5.64e-06	3.48e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IRS1—obesity	5.57e-06	3.44e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SCARB1—obesity	5.55e-06	3.43e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PRKCD—obesity	5.54e-06	3.42e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—obesity	5.48e-06	3.38e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PRKAR2B—obesity	5.46e-06	3.37e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR2A—obesity	5.42e-06	3.35e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—DCN—obesity	5.42e-06	3.35e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—C3—obesity	5.41e-06	3.34e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—obesity	5.41e-06	3.34e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SREBF1—obesity	5.39e-06	3.33e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—POMC—obesity	5.36e-06	3.31e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—INS—obesity	5.33e-06	3.3e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	5.32e-06	3.29e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CPT1A—obesity	5.27e-06	3.26e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL2—obesity	5.25e-06	3.24e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GOT2—obesity	5.24e-06	3.24e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	5.17e-06	3.2e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NAMPT—obesity	5.17e-06	3.19e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF1—obesity	5.16e-06	3.19e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKT2—obesity	5.16e-06	3.19e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IRS2—obesity	5.15e-06	3.18e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGT—obesity	5.14e-06	3.18e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	5.14e-06	3.17e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LIPC—obesity	5.14e-06	3.17e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GCK—obesity	5.14e-06	3.17e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—FASN—obesity	5.13e-06	3.17e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—BCHE—obesity	5.11e-06	3.16e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOC3—obesity	5.1e-06	3.15e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	5.07e-06	3.13e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LEP—obesity	5.04e-06	3.11e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOE—obesity	5.04e-06	3.11e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CAV1—obesity	4.99e-06	3.08e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOA1—obesity	4.98e-06	3.08e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CETP—obesity	4.96e-06	3.06e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CD—obesity	4.95e-06	3.06e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2E1—obesity	4.93e-06	3.05e-05	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PIK3CA—obesity	4.91e-06	3.03e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SDC1—obesity	4.9e-06	3.03e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SERPINE1—obesity	4.9e-06	3.03e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NQO1—obesity	4.88e-06	3.01e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AKR1C3—obesity	4.82e-06	2.98e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ESR1—obesity	4.81e-06	2.97e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	4.77e-06	2.95e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TYK2—obesity	4.77e-06	2.94e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PRKCB—obesity	4.75e-06	2.94e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—F2—obesity	4.75e-06	2.94e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SCARB1—obesity	4.75e-06	2.93e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	4.73e-06	2.92e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RHOA—obesity	4.73e-06	2.92e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—BAD—obesity	4.69e-06	2.9e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	4.68e-06	2.89e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOS3—obesity	4.68e-06	2.89e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3R1—obesity	4.68e-06	2.89e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GCG—obesity	4.67e-06	2.89e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC2A4—obesity	4.67e-06	2.89e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	4.62e-06	2.85e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYCS—obesity	4.61e-06	2.85e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SREBF1—obesity	4.61e-06	2.85e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CG—obesity	4.55e-06	2.81e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GOT1—obesity	4.53e-06	2.8e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GGT1—obesity	4.53e-06	2.8e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IRS1—obesity	4.49e-06	2.78e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GOT2—obesity	4.48e-06	2.77e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NCOA1—obesity	4.46e-06	2.76e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PIK3CA—obesity	4.46e-06	2.75e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	4.42e-06	2.73e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—STK11—obesity	4.4e-06	2.72e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP19A1—obesity	4.4e-06	2.72e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—FASN—obesity	4.39e-06	2.71e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—BCHE—obesity	4.37e-06	2.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—POMC—obesity	4.33e-06	2.67e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MTOR—obesity	4.32e-06	2.67e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CB—obesity	4.32e-06	2.67e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—INS—obesity	4.3e-06	2.66e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL2—obesity	4.23e-06	2.62e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2E1—obesity	4.21e-06	2.6e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NQO1—obesity	4.17e-06	2.57e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF1—obesity	4.16e-06	2.57e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKT2—obesity	4.16e-06	2.57e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—COMT—obesity	4.09e-06	2.52e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	4.08e-06	2.52e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	4.04e-06	2.5e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARGC1A—obesity	4.03e-06	2.49e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GNB3—obesity	4.03e-06	2.49e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HMOX1—obesity	4.01e-06	2.48e-05	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AKT1—obesity	4.01e-06	2.48e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CD—obesity	4e-06	2.47e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GCG—obesity	3.99e-06	2.47e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC2A4—obesity	3.99e-06	2.47e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CA—obesity	3.96e-06	2.45e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SERPINE1—obesity	3.95e-06	2.44e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—obesity	3.95e-06	2.44e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYCS—obesity	3.94e-06	2.44e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GNAS—obesity	3.92e-06	2.42e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GGT1—obesity	3.87e-06	2.39e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GOT1—obesity	3.87e-06	2.39e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TYK2—obesity	3.85e-06	2.38e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOB—obesity	3.84e-06	2.37e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RHOA—obesity	3.81e-06	2.36e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NCOA1—obesity	3.81e-06	2.35e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3R1—obesity	3.77e-06	2.33e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOS3—obesity	3.77e-06	2.33e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—STK11—obesity	3.76e-06	2.32e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP19A1—obesity	3.76e-06	2.32e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP9—obesity	3.75e-06	2.32e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LPL—obesity	3.67e-06	2.27e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAPK8—obesity	3.65e-06	2.26e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AKT1—obesity	3.64e-06	2.25e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CA—obesity	3.6e-06	2.22e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GPX1—obesity	3.58e-06	2.21e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—COMT—obesity	3.49e-06	2.16e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CD36—obesity	3.49e-06	2.15e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MTOR—obesity	3.48e-06	2.15e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CB—obesity	3.48e-06	2.15e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARGC1A—obesity	3.44e-06	2.13e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GNB3—obesity	3.44e-06	2.13e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HMOX1—obesity	3.43e-06	2.12e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GNAS—obesity	3.35e-06	2.07e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—STAT3—obesity	3.34e-06	2.06e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MTHFR—obesity	3.3e-06	2.04e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOB—obesity	3.28e-06	2.03e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARA—obesity	3.24e-06	2e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AKT1—obesity	3.23e-06	2e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—obesity	3.18e-06	1.97e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AGT—obesity	3.14e-06	1.94e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LPL—obesity	3.13e-06	1.94e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MYC—obesity	3.1e-06	1.92e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TGFB1—obesity	3.09e-06	1.91e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOE—obesity	3.07e-06	1.9e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GPX1—obesity	3.06e-06	1.89e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CAV1—obesity	3.05e-06	1.88e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOA1—obesity	3.04e-06	1.88e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP9—obesity	3.03e-06	1.87e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CD36—obesity	2.98e-06	1.84e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAPK8—obesity	2.94e-06	1.82e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AKT1—obesity	2.94e-06	1.81e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.91e-06	1.8e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MTHFR—obesity	2.82e-06	1.74e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CG—obesity	2.77e-06	1.71e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARA—obesity	2.77e-06	1.71e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—STAT3—obesity	2.69e-06	1.66e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AGT—obesity	2.68e-06	1.66e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARG—obesity	2.68e-06	1.65e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—POMC—obesity	2.64e-06	1.63e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CA—obesity	2.63e-06	1.63e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOE—obesity	2.63e-06	1.62e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—INS—obesity	2.63e-06	1.62e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CAV1—obesity	2.6e-06	1.61e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOA1—obesity	2.6e-06	1.6e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MYC—obesity	2.5e-06	1.55e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TGFB1—obesity	2.5e-06	1.54e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.49e-06	1.54e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CD—obesity	2.44e-06	1.51e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALB—obesity	2.41e-06	1.49e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CG—obesity	2.37e-06	1.46e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—obesity	2.33e-06	1.44e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3R1—obesity	2.3e-06	1.42e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NOS3—obesity	2.3e-06	1.42e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARG—obesity	2.29e-06	1.41e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—POMC—obesity	2.26e-06	1.39e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—INS—obesity	2.24e-06	1.39e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKT1—obesity	2.15e-06	1.33e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CB—obesity	2.13e-06	1.31e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CA—obesity	2.12e-06	1.31e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS2—obesity	2.11e-06	1.3e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CD—obesity	2.08e-06	1.29e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALB—obesity	2.06e-06	1.27e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NOS3—obesity	1.97e-06	1.22e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3R1—obesity	1.97e-06	1.22e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—obesity	1.88e-06	1.16e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CB—obesity	1.82e-06	1.12e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS2—obesity	1.8e-06	1.11e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKT1—obesity	1.73e-06	1.07e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CA—obesity	1.3e-06	8.01e-06	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CA—obesity	1.11e-06	6.84e-06	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AKT1—obesity	1.06e-06	6.54e-06	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AKT1—obesity	9.05e-07	5.59e-06	CbGpPWpGaD
